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Summary: The half-life of [3H]hyaluronic acid in rabbit knee joints was estimated using two methods:
(i) by following the [3H]hyaluronan content of the synovial fluid after intra-articular injection and
(ii) by following the 3H2O radioactivity of plasma after intra-articular injection of [3H]hyaluronan.
For normal rabbits we obtained a half-life of 15.8 hours (method I) and 17.5 ± 1.0 hours (mean ± SEM, method II),
respectively. The second method was used to estimate the kinetics of the hyaluronan elimination from normal,
sham-operated, as well as from osteoarthritic rabbit knee joints (Colombo model of osteoarthritis). Four weeks after
injury, during the developing phase of osteoarthritis, the half-life of hyaluronan rose significantly to 23.5 ± 2.1
hours and returned to normal levels (17.4 ± 2.7 hours) 12 weeks after the operation (osteoarthritis developed). At
the stage of developed osteoarthritis, the clearance rates were considerably higher than in normal rabbits.
Introduction
Hyaluronic acid (hyaluronan) is a high molecular mass
component of the synovial fluid that is responsible for
its unique viscoelasticity as well as for other specific
properties. Synovial fluid fulfills several physiological
protective functions in the joint cavity such as shock
absorption, traumatic energy dissipation and storage,
radical scavenging and the protective coating of the ar-
ticular cartilage surface and of the inner lining of the
synovium, as well as controlling the "traffic" between
the synovial vessels and the cartilage by an exclusion
effect on migrating cells and larger molecules (1). Re-
cently, repeated intra-articular injections of hyaluronan
have been widely used in the treatment (1 —4) of osteo-
arthritis.
Hyaluronan of the synovial fluid is synthesized by lining
cells and leaves the joint cavity via the lymphatic system
(5—7). The mean intrasynovial half-life of hyaluronan
in rabbits has been found with high molecular mass
[3H]hyaluronic acid (Mr > 6 106) to be 13.2 hours
and with [3H]hyaluronic acid of lower Mr (0.09 X 106)
to be 10.2 hours (6). After entering the circulation, it is
quickly cleared from the blood by the sinusoidal endo-
thelial cells of the liver (t-/2 = 2.5-4.5 min, (8, 9)).
Therefore, the concentration of hyaluronan in serum is
several orders of magnitude lower (30—40 §/1, (7, 10))
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than in synovial fluid (3 g/l). In osteoarthritis the syno-
vial fluid in general is more abundant and less viscous,
whereas the concentration of hyaluronan is decreased
and its molecular mass is reduced (2). The content of
hyaluronan in the joint is elevated, because the volume
of synovial fluid is enhanced in osteoarthritis (11). These
alterations severely impair the physiological functions
of the synovial fluid. In osteoarthritic synovium from
dogs an enhanced rate of hyaluronan synthesis has been
described (12, 13). It has not been reported whether the
elimination rate of hyaluronan from the joint is changed
under osteoarthritic conditions. Therefore, we have esti-
mated the intrasynovial half-life of biochemically syn-
thesized [3H]hyaluronic acid using the osteoarthritis
model of Colombo et al. (14). Using an experimental
model it is possible to measure the half-life of hyaluro-
nan at different stages of the osteoarthritic process and
to answer the question whether the determination of hy-
aluronan elimination rates of injured knee joints may be
useful for the early diagnosis of osteoarthritis.
Materials and Methods
Animals
Nineteen chinchilla rabbits, weighing 2.7 to 3.2 kg, were randomly
divided into four groups: non-operated control animals (n = 5),
sham-operated animals (n = 3), osteoarthritis group "4 weeks after
operation" (n = 5) and osteoarthritis group "12 weeks after opera-
tion" (n = 6). In the osteoarthritis groups the fibular collateral and
sesamoid ligament of the left knee were dissected and 4—5 mm of
the anterior lateral area of the exposed meniscus was removed (14).
In the sham-operated group the joint cavity was opened, the patella
dislocated, as in the case of operation, and then reset. Finally the
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joint capsule and skin were sutured. Colombo et al. (14) only cut
the skin in the sham-operated group.
For operation the animals were anaesthetized with 50 mg/kg keta-
mine (Ketanest®, Parke-Davis) and 5 mg/kg xylazin (Rompun
vet®, Bayer).
Histology
After sacrifice both femur condyles were excised, fixed in 100 g/1
formalin in 0.05 mol/1 phosphate buffer (pH 7.2) containing 5 g/1
cetyl trimethylammonium bromide, decalcified with 50 g/1 nitric
acid and sections stained with haematoxylin/eosin and according
to Masson-Goldner's method (15), respectively.
Synovium harvested together with both the joint capsule and pa-
tella was fixed in Kryofix® (Merck 5211) and embedded in paraffin
after decalcification with 50 g/1 nitric acid.
Harvesting of synovial fluid by the dilution method
(11, 16)
The animals were anaesthetized with thiopental-Na (Trapanal®,
Byk Gulden, Germany) and received a 2.0 ml intra-articular injec-
tion of 5 g/1 hydroxyethyl starch (average relative molecular mass
200 000, Fresenius AG, Bad Homburg) in saline. After passive mo-
tion of the joint for 5 min the mixture of hydroxyethyl starch solu-
tion and synovial fluid was aspirated. From the difference in the
hydroxyethyl starch concentration between the injected hydroxy-
ethyl starch (HES) solution and aspirated mixture, the volume of
the synovial fluid and dilution factor of the aspirated mixture
were calculated:
volume of synovial fluid =
volume of injected HES solution X difference in HES concentration
HES concentration of the aspirated mixture
dilution factor
_ HES concentration of the injected HES solution
difference in HES concentration
Determination of hydroxyethyl starch
The hydroxyethyl starch concentration of joint aspirates was deter-
mined as described for "depot glucose" in I.e. (16). Briefly, 100
μΐ test solution and 20 μΐ 420 g/l KOH were heated in a small test
tube (diameter 11 mm, length 100 mm) in boiling water for 5 min.
After cooling, 50 μΐ 20 g/1 Na2SO4 solution and 1 ml 96% alcohol
(0.960 1/1, volume fraction 0.96) were added and the tubes kept
at 6 °C over night. After centrifugation at 2200 g for 10 min, the
precipitate was washed with 500 μΐ of 80% alcohol (0.8 1/1, volume
fraction 0.8), dried and mixed with 2.5 ml 0.6 mol/1 HC1. The
tubes were sealed and heated in boiling water for 5 hours. The acid
hydrolysate (400 μΐ) was neutralized in a small test tube by adding
100 μΐ of a saturated KHCO3 solution. The developing CO2 was
eliminated by vigorous shaking. The glucose concentration of the
neutralized hydrolysate was determined using the Test Kit "Glu-
cose-Test 180" (Fermognost, Feinchemie Sebnitz GmbH, Ger-
many) according to the manufacturer's instructions. The intra- and
inter-assay coefficients of variation of the hydroxyethyl starch de-
termination were 1.2% and 2.0%, respectively.
Biosynthesis of [3H]hyaluronic acid (6, 8)
After sacrifice, 4 normal rabbit knee joints were sluiced twice by
intra-articular injection of 2 ml phosphate buffered saline. Af-
terwards 2 ml of a 5 g/1 solution of trypsin (1 : 250) in Leibovitz
L-15 medium were injected into each knee joint and aspirated after
15 min. This treatment was repeated two times. Finally the knee
joints were sluiced with 3 ml phosphate buffered saline. Fetal calf
serum was added to the pooled trypsin solutions and the last wash
(volume fraction 0.05). The cells were collected, seeded at a den-
sity of 53 X 103/cm2 and cultivated with Dulbecco's modified
Eagle's medium (DMEM) containing 0.5 mmol/1 cysteine and fetal
calf serum (volume fraction 0.2). For biosynthesis the first subcul-
ture of the cells was used. After the cells reached confluence the
medium was changed to DMEM containing 0.5 mmol/1 cysteine,
0.9 mmol/1 glucosamine hydrochloride, 1.85 GBq/1 3H-labelled so-
dium acetate (DuPont, Germany) and fetal calf serum (volume
fraction 0.1). The medium (15 ml per dish, 13.5 cm diameter) was
changed every two days. All solutions contained 10s IU/1 penicil-
lin, 100 mg/1 streptomycin and 0.5 mg/1 amphotericin. The media
were pooled, concentrated and freed from excessive 3H-labelled
sodium acetate by ultrafiltration.
[3H]Hyaluronic acid was isolated from the concentrated medium
by density gradient centrifugation (135 000 g, 60 h, 4 °C) in asso-
ciative and dissociative conditions as described by Fr ser et al.
(8). Proteins originating from fetal calf serum were eliminated by
the centrifugation in associative conditions (1.505 kg/1 CsCl),
whereas link proteins, hyaluronic acid, and proteoglycan subunits
were separated by centrifugation in dissociative conditions (4 mol/1
guanidinium hydrochloride, CsCl, 1.455 kg/1). Link proteins as-
semble in the upper part of the tube, hyaluronic acid in the middle
zone (1.425 to 1.46 kg/1) and proteoglycan subunits in the lower
part of the tube. The hyaluronan contained in the middle zone was
isolated and centrifuged again in dissociative conditions. CsCl and
guanidinium hydrochloride of the [3H]hyaluronan solution were
eliminated by ultrafiltration. It has to be taken under consideration
that hyaluronan is easily adsorbed on the ultrafiltration membrane.
While concentrating [3H]hyaluronan solutions with aid of micro-
concentrators (Centricon-10, Amicon), the hyaluronan concentra-
tion of the solution did not rise, since the hyaluronan of the filtered
solution was adsorbed on the membrane. After filtration, the gel-
like hyaluronan (filtercake) had to be solubilized by stirring with
a small magnetic stirring bar. Levick et al. made similar observa-
tions when filtering hyaluronan solution through a 0.45 μηι Milli-
pore membrane (17).
Using 143 cm2 of confluent synovial cells, we obtained 1804 μg
[3H]hyaluronic acid from 253 MBq 3H-labelled sodium acetate.
The 3H activity of the solution was 200 MBq/1, the specific activity
1.3 TBq/kg hyaluronan. The labelled material was shown to be
96.4% hyaluronan by degradation with hyaluronidase from Strepto-
myces hyalurolyticus and chromatography in Sephadex G-50.
Measurement of hyaluronan concentration
The concentration of hyaluronan was determined using the thiobar-
bituric acid method (18) after enzymatic digestion of the samples
with hyaluronidase from Streptomyces hyalurolyticus nov. sp. (Cal-
biochem, EC 4.2.99.1). This enzyme specifically cleaves hyaluro-
nan to unsaturated oligosaccharides which were quantified by reac-
tion with thiobarbituric acid (18). Chondroitin sulphate, chondroi-
tin, heparin, keratan sulphate, and chitin were not degraded by this
hyaluronidase (19).
Briefly, 50 μΐ joint aspirate (mixture of hydroxyethyl starch and
synovial fluid) containing between 0.2 and 1.0 g/1 hyaluronan were
incubated with 50 μΐ 0.04 mol/1 sodium acetate buffer (pH 5.2)
and 50 μΐ hyaluronidase (105 turbidity-reducing units/1) in 0.4 mol/1
sodium acetate buffer (pH 5.2) at 60 °C for 3.5 h. For each aspirate
an own blank was prepared (50 μΐ aspirate, 50 μΐ 0.04 mol/1 sodium
acetate buffer pH 5.2, 50 μΐ 0.4 mol/1 sodium acetate buffer pH
5.2). The assay was performed as described byJourdian et al. (18).
The absorbance of the butanol layer was determined at 552 nm.
Recovery of hyaluronan upon addition to aspirates was 98%. The
intra- and inter-assay coefficients of the hyaluronan determination
were 1.06% and 1.9%, respectively. Hyaluronan was dissolved in
hydroxyethyl starch solution for establishing the standard curve.
To evaluate the thiobarbituric acid method, the hyaluronan concen-
tration of the joint aspirates was also quantified using the radiometric
assay of Pharmacia AB (Uppsala, Sweden). The correlation between
the methods was very high (correlation coefficient r = 0.98).
Estimation of half-life of hyaluronan by following the
3H content of the joint fluid after intra-articular
injection of [3H]hyaluronic acid (method I)
Three normal rabbits received an intra-articular injection of 0.475
ml [3H]hyaluronic acid (12 kBq, 9.6 μg hyaluronan) into their right
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Tab. 1 Elimination of [3H]hyaluronan from normal rabbit knee
joints (method I).
Each of the three rabbits received an intra-articular injection of
[3H]hyaluronan into the right knee joint. Synovial fluid was har-
vested by the dilution method after the indicated time, and 3H ac-
tivity was measured. Amount of intra-articularly injected [3H]hya-
luronan: 9.6 μ§. Hyaluronan content of normal rabbit knee joints:
910 ± 90 μ§ (mean ± SEM), n = 6. Clearance = kHA ' distribu-
tion volume. For the value of kHA see table 2.
Time after injection
[h]
12.00
24.25
48.00
Volume of
synovial fluid
[μΐ]
688
590
1003
3H Radioactivity of
synovial fluid
[kBq/1]
10384
6903
1464
[3H]Hyaluronan
content
[Bq/joint]
7146
4073
1469
Clearance3
[μΐ/h]
30.0
25.8
43.8
a
 These clearance values are higher than those in table 2 because the synovial fluid volume was
augmented through the intra-articular injection of 475 μΐ [3H]hyaluronan solution.
knee joints. Synovial fluid from the first rabbit was harvested 12
hours after injection, from the second one after 24 hours and from
the third one after 48 hours. Before mixing with the scintillator
the joint fluids had to be digested by hyaluronidase. Without this
preceding digestion, the hyaluronic acid slowly precipitates and
no reproducible count rates will be obtained. The total activity of
[3H]hyaluronic acid of the synovial fluid can be calculated, because
the dilution factor of the aspirated mixture and volume of synovial
fluid are obtained by the dilution method.
Estimation of half-life of hyaluronan by measuring
3H2O radioactivity in blood (6) after intra-articular
injection of [3H]hyaluronic acid (method II)
A solution (0.44 to 0.60 ml) of [3H]hyaluronic acid (68-92 μg
hyaluronan, 88-120 kBq) in phosphate buffered saline containing
105 U/l penicillin, 0.1 g/1 streptomycin and 0.5 mg/1 amphotericin
was injected into each left knee joint with a needle of 0.6 mm
diameter inserted through the patellar ligament. For injection the
animals were briefly anaesthetized with thiopental-Na (Trapanal®,
Byk Gulden, Germany). Blood samples were taken before injection
and 7, 14, 25, 33, 49,121, 145, 169, 193 and 217 hours after injec-
tion.
Measurement of the 3H2O radioactivity
The rabbit plasma (200 μΐ) was added to 10 ml Ready Gel (Beck-
man Instruments, Inc.) in glass vials, briefly mixed, 800 μΐ 0.125
mol/1 HC1 solution added, mixed until clear and measured in a
liquid scintillation counter (LSC 6000 SC, Low Level Version,
Beckman Instruments, Inc.). The error of the measure was 2%, the
counting time 200 minutes.
Gel permeation chromatography
Chromatography of [3H]hyaluronan and plasma samples was per-
formed on a Sepharose CL-6B column (20 mm X 500 mm) equili-
brated with 0.01 mol/1 phosphate buffer (pH 7.4) containing 0.15
mol/1 NaCl and 0.2 g/1 NaN3. Void volume of the column (V0) was
determined by Dextran Blue 2000, the total volume (Vt) by
K3[Fe(CN)6].
Results
Kinetics of the elimination of [3H]hyaluronan
from normal rabbit knee joints determined
from the decrease of [3H]hyaluronan content
of synovial fluid (method I)
Measured 3H activities (kBq/1) of synovial fluids har-
vested 12, 24 and 48 hours after intra-articular injection
of [3H]hyaluronan are given in table 1. Since the dilution
method reveals both the volume of synovial fluid and
the dilution factor of the aspirated mixture of hydroxy-
ethyl starch solution and joint fluid, the [3H]hyaluronan
content of the joint fluid was calculated (tab. 1).
The semilogarithmic plot of the [3H]hyaluronan content
versus time after intra-articular administration reveals
the mono-exponential decline in radioactivity character-
istic of first-order kinetics (fig. 1) which is described by
the relationship
dX
dt -Λ- [Eq. 1],
where X is the amount of [3H]hyaluronan (Bq) in the
joint fluid at time t after injection. The term knA is the
apparent first-order elimination rate constant for hyalur-
onan. After Laplace transformation (20) the equation is
k .
 t
log X = log X0 - -t^— [Eq. 2].
2.303
X0 represents the amount of [3H]hyaluronan injected
into the joint cavity.
Although the rabbits in table 1 exhibit differing synovial
fluid volumes, the semilogarithmic plot of [3H]hyaluro-
nan content of the three rabbits was consistently linear
over time indicating precise following of formulation in
equation [2]. In contrast to the [3H]hyaluronan content
versus time plot, the [3H]hyaluronan concentration
(kBq/1) can only be plotted versus time if all synovial
fluid volumes are identical.
10000
£. 1000
10 20 30
Time alter injection [h]
40 50
Fig. 1 Time course of [3H]hyaluronan content of the joint
following intra-articular injection of [3H]hyaluronan (method I).
Correlation coefficient r = —0.97.
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The elimination rate constant kHA can be calculated
from the slope of the log Bq/joint versus time plot (fig.
1) that is equal to — kHA/2.303. The constant k^ ex-
presses the fraction of the original amount of injected
[3H]hyaluronan that is removed in unit time (h"1): a kHA
value of 0.0438/h represents a turnover of 4.38%. The
half-life of the [3H]hyaluronan is obtained from the rela-
tionship
t1/2 = ln2/kHA.
The kinetic values can also be calculated by the Pharma-
cokinetic and Pharmacodynamic Data Analysis System
TOPFIT (21) using the non-compartmental analysis
(values see tab. 2).
Kinetics of the elimination of [3H]hyaluronan
from rabbit knee joints determined by
following the 3H2O activity of the blood
(method II) after intra-articular injection
[3H]Hyaluronan injected intra-articularly enters the
blood in a first-order kinetic. After entering the blood,
the tritium of the acetyl groups is quickly metabolized
in the liver overwhelmingly to 3H2O. The 3H activity
of the blood rises to cmax at time tniax and decreases
monoexponentially (fig. 2). The term tmax is solely a
function of k^ and the elimination rate constant Ke
of the 3H2O (20). The ascending part of the curve
(fig. 2) represents the elimination of [3H]hyaluronan
from the joint cavity into the blood (rise of 3H2O
activity in blood) and the descending curve represents
the elimination of 3H2O from the blood (Ke) into urine
and faeces. The elimination rate constant Ke for
plasma 3H2O can be calculated from the slope (-KJ
2.303) of the descending straight curve. The corre-
sponding constants for the elimination of [3H]hyaluro-
nan (kHA) from the knee joints were derived by log-
linear regression from the differences (residual values)
between the observed levels of plasma 3H activity
(ascending curve) at each time point and the corre-
sponding values from backward extrapolation of the
regressions for 3H2O (6, 20, 22). The residual concen-
trations of the [3H]hyaluronan in the joint cavity were
semilogarithmically plotted versus time after injection
(fig. 3), and kHA was calculated from the slope (—kHA/
2.303) of the straight line. Application of the method
of residuals is only possible if knA > ^  (20). The
Tab. 2 Kinetics of [3H]hyaluronan elimination determined from
the decrease of the [3H]hyaluronan content of synovial fluid in
normal rabbit knee joints (method I).
t./2
M
MRT0-
M
0.0438 15.8 23.8
kHA: elimination rate constant for synovial [3H]hyaluronan.
ti/2: half-life. MRTo-^: mean residence time.
half-life of [3H]hyaluronan in the rabbit knee joint
was obtained from the relationship t1/2 = ln2/kHA·
The kinetic terms kHA, ti/2, and mean residence time can
also be calculated by the TOPFIT program assuming a
one compartment disposition and one segment absorp-
tion. Using this method, we obtained the same values as
with the residual's method.
Kinetics of the elimination of [3H]hyaluronan
from normal, sham-operated, and
osteoarthritic rabbit knee joints
Results obtained for the elimination of [3H]hyaluronan
from the joint cavity for the different groups are given
in table 3. Statistical analysis was performed employ-
ing the non-parametric Kruskal-Wallis test (program
SPSS). Results of the statistical evaluation are shown
in table 4. Half-lives of [3H]hyaluronan determined in
the knee joints of all animals are compiled in figure
4. Half-life of hyaluronan, mean residence time and
tmax were significantly higher in the osteoarthritis
group "4 weeks after operation" (developing osteoar-
thritis) than in the group of non-operated animals (tab.
4) and achieved normal values 12 weeks after the
operation (developed osteoarthritis). The differences
between the group of non-operated control animals
and the osteoarthritis group "12 weeks after operation"
were not significant (tab. 4). Differences between the
sham-operated group and the osteoarthritis group "4
100 r
10
50 100 150 200 250
Time after injection [h]
300 350
Fig. 2 Time course of 3H radioactivity in plasma following intra-
articular injection of [3H]hyaluronan (method II).
100 r
10
10 20 30 40
Time after injection [h]
50
Fig. 3 Elimination of [3H]hyaluronan from the synovial cavity of
non-operated control animals determined according to the method
of residuals.
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Tab. 3 Kinetics of [3H]hyaluronan elimination from normal and injured rabbit knee joints estimated
by following plasma 3H radioactivity after intra-articular injection.
Values are given as mean ± SEM.
Experimental
group
Non-operated
Sham-operated
Four weeks after
operation
Twelve weeks
after operation
[h"]
0.0402 ± 0.0024
n = 5
0.0401 ± 0.0080
n = 3
0.0306 ± 0.0025
n = 5
0.0444 ± 0.0061
n = 6
[h]
17.48 ± 1.04
n = 5
18.80 ± 3.67
n = 3
23.52 ± 2.09
n = 5
17.38 ± 2.66
n = 6
tmax
[h]
60.64 ± 1.52
n = 5
59.47 ± 13.52
n = 3
76.76 ± 7.63
n = 5
57.30 ± 6.87
n = 6
M
29.70 ± 2.03
n = 5
35.00 ± 5.17
n = 3
38.76 ± 3.12
n = 5
29.08 ±4. 12
n = 6
Clearance
[μΐ/h]
18.0
n - 2
27.2 ± 7.1
n = 3
29.1
n = 2
33.1 ± 5.6
n = 6
Volume of
synovial fluid
[μΐ]
433 ± 28
n = 5a
719 ± 108
n = 6a
938 ± 209
η = 4a
844 ± 345
η = 6
kHA: elimination rate constant for synovial [3H]hyaluronan.
t./a: half-life. ΜΚΤ0_^: mean residence time.
tmax: time of the maximum plasma 3H radioactivity.
a
 Additional values for the calculation of an average volume were
taken from a similar experiment.
Tab. 4 Statistical evaluation using the Kruskal-Wallis test. Differences between the groups were
considered significant if the ρ value was lower than 0.05 (in bold).
Comparison between the groups
Non-operated/4 weeks after operation
Non-operated/sham operation
Four weeks/ 12 weeks after operation
Non-operated/ 12 weeks after operation
Sham-operation/4 weeks after operation
kHA
[h->]
0.028
0.882
0.068
0.715
0.297
t*
Μ
0.028
0.882
0.068
0.715
0.297
W
[h]
0.028
0.882
0.083
0.855
0.297
MRT0_,
M
0.047
0.456
0.068
0.648
0.655
Volume of
synovial fluid
[μΐ]
0.014
0.045
0.670
0.045
0.286
weeks after operation" were not significant due to the
high variance and low animal number in the sham-
operated group. It was remarkable that one animal of
the sham-operated group, which also had elevated
half-life, tm'ax and mean residence time, did not use his
sham-operated leg to walk. Histological examination
revealed no osteoarthritic changes in the articular carti-
lage layer of this leg.
Normal Sham- 4 Weeks 12 Weeks
after after
operation operation
Fig. 4 Scattergrams of half-life of [3H]hyaluronan in normal and
injured rabbit knee joints.
Elimination of 3H2O from blood
The mean values for the kinetic terms of the several
groups are given in table 5. The mean half-life of plasma
3H2O did not differ significantly between the groups.
Histological findings
The opening of the joint capsule in the sham-operated
group caused a slight disorganization of chondrocytes in
comparison to the contralateral non-operated knee joint.
At 4 weeks post-surgery, the cartilage layer was charac-
terized by slight fibrillations, a heavy disorganization of
chondrocytes, clones near the articular surface and some
fissures. The cartilage layer was very rich in cells. Only
one animal of this group showed a partial erosion of the
cartilage layer. At 12 weeks after surgery the alterations
were more pronounced. The cartilage layer displayed fi-
brillations, disorganization of cells and deep clefts, but
only one animal showed areas where the bone was de-
nuded.
At 6 weeks after surgery, the synovium showed a low
hyperplasia and a slight cell infiltration. In addition, 12
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Tab. 5 Kinetics of elimination of 3H2O from blood. Values are given as mean ± SEM.
Group
Non-operated
Ke [h-'] 0.0054 ± 0.0005
t./2 [h] 132.4 ±13.5
Sham-operated
0.0064 ± 0.0005
110.4 ±9.6
Four weeks after
operation
0.0050 ± 0.0002
138.0 ± 5.8
Twelve weeks after
operation
0.0051 ± 0.0004
138.5 ± 10.8
elimination rate constant of 3H2O from blood.
weeks after injury, the synovium was only slightly hy-
perplastic.
Size-exclusion chromatography of
[3H]hyaluronan and plasma samples
Synthesized [3H]hyaluronan eluted together with Blue
Dextran 2000 (average MT 2 · 106) at the void volume of
the Sepharose CL-6B column (fig. 5). Since the approxi-
mate exclusion limit of Sepharose CL-6B for polysac-
charides is given as 1 · 106 (Mr), the [3H]hyaluronan
synthesized in cell culture was of high molecular mass.
Brown et al. determined a Mr of about 6 · 106 for [3H]hy-
aluronan synthesized by human synovial cells (6). After
enzymatic digestion with hyaluronidase from Streptomy-
ces hyalurolyticus, the 3H activity appeared entirely at
Vt of the column (fig. 5). In concordance with the fact
that hyaluronan is rapidly degraded in lymph nodes and
in liver to yield mainly 3H2O, the plasma 3H activity
appeared for the most part at Vt, consistent with the be-
haviour of 3H2O. Separating rabbit plasma, we obtained
different results. In some rabbits we still found a small
3H activity at V0 nine hours after injection (fig. 6).
Forty-six hours after injection (fig. 7), the peak at V0
was considerably lower, but rose again 214 hours after
injection (fig. 8). To decide whether the peak at V0 con-
tained [3H]hyaluronan, the void volume peak was incu-
400
& 300
200
100
50 100
Button volume [ml]
150
Fig. 5 Size-exclusion chromatography of [3H]hyaluronan on
Sepharose CL-6B.
o, 4.3 kBq [3H]hyaluronan separated on the column;
A, 4.3 kBq [3H]hyaluronan digested with hyaluronidase from
Streptomyces hyalurolyticus and analyzed on the column;
·, absorbance of Dextran Blue 2000 was measured at 625 nm, that
of K3[Fe(CN)6] (D) at 410 nm.
Eluant: 0.1 mol/1 phosphate buffer, 0.15 mol/1 NaCl, 0.2 g/1 NaN3,
pH 7.4; applied sample volume: 1 ml; recovered fractions: 4 ml;
elution rate: 12 ml/h.
0.5
0.4
0,3
0.2
0.1
50 100
Elution volume [ml]
150
Fig. 6 Size-exclusion chromatography on Sepharose CL-6B of
rabbit plasma (osteoarthritis group "4 weeks after operation").
Blood was taken 9 hours after intra-articular injection of [3H]hya-
luronan.
o, 3H radioactivity of the elution fractions;
·, Dextran Blue 2000;
D, K3[Fe(CN)6].
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Fig. 7 Size-exclusion chromatography on Sepharose CL-6B of
rabbit plasma (osteoarthritis group "4 weeks after operation").
Blood was taken 46 hours after intra-articular injection of [3H]hya-
luronan.
o, 3H radioactivity of the elution fractions;
·, Dextran Blue 2000;
D, K3[Fe(CN)6].
bated with hyaluronidase from Streptomyces hyalurolyti-
cus and analyzed again by size-exclusion chromato-
graphy on Sepharose. The void volume peak was com-
pletely eliminated and appeared at Vt (fig. 9). This
indicates that a small part of 3H-labelled acetyl groups
is possibly reutilized for the synthesis of lipid or other
substances (22), may be even of hyaluronan.
Hyaluronan analysis
Hyaluronan concentration and content of the synovial
fluids are compiled in table 6. Using the Kruskal-Wallis
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Fig. 8 Size-exclusion chromatography on Sepharose CL-6B of
rabbit plasma (osteoarthritis group "4 weeks after operation").
Blood was taken 214 hours after intra-articular injection of [3H]hy-
aluronan.
o, 3H radioactivity of the eluation fractions;
·, Dextran Blue 2000;
D, K3[Fe(CN)6].
test for statistical evaluation we found a significantly
lower hyaluronan concentration in the osteoarthritis
group "4 weeks after operation" in comparison to the
osteoarthritis group "12 weeks after operation", whereas
hyaluronan content of the osteoarthritis group "4 weeks
after operation" was significantly higher than that of the
group of non-operated animals.
Discussion
After intra-articular injection of small amounts of
[3H]hyaluronan, the kinetics of hyaluronan elimination
from the joint can be estimated
(i) by following the [3H]hyaluronan content of the joint
fluid after intra-articular injection or
(ii) by following 3H activity in blood after intra-articular
injection (6).
Using both methods, we obtained a half-life of 15.8
hours and 17.5 hours, respectively, for normal rabbit
knee joints. These values are on the same order of mag-
nitude as those found by Brown et al. (t/2 =13.2 hours,
method II, (6)). There are two differences between the
investigations:
(i) we used synovial cells from rabbits for the [3H]hya-
luronan synthesis, Brown et al. used synovial cells of
human origin and
1
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50 100
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Fig. 9 Size-exclusion chromatography on Sepharose CL-6B of
the void volume fraction, containing 3H radioactivity, after diges-
tion with hyaluronidase from Streptomyces hyalurolyticus.
o, 3H radioactivity of the eluation fractions;
·, Dextran Blue 2000;
D, K3[Fe(CN)6].
(ii) we used chinchilla rabbits whereas Brown et al. used
English lop-eared rabbits. We suppose that the differ-
ences in hyaluronan half-life reflect breed-related varia-
tions.
Four weeks after surgery, during the phase of developing
osteoarthritis, the half-life of hyaluronan rose signifi-
cantly to 23.5 hours and returned to normal levels 12
weeks after operation (developed osteoarthritis). Simi-
larly tmax and mean residence time were enhanced 4
weeks after operation and dropped to normal levels 12
weeks after operation. Correspondingly, the fractional
turnover rate of hyaluronan (kHA' 100) was lowered
from 4.02% to 3.06% during the phase of developing
osteoarthritis but was not significantly different from the
non-operated control group in the phase of developed
osteoarthritis.
We suppose that changes in the synovium might be re-
sponsible for the elevated half-life of hyaluronan be-
cause high molecular mass compounds, such as hyaluro-
nan and proteoglycans, leave the joint through the inter-
cellular space and the lymphatic endothelium (5, 6).
Therefore, alterations of the synovium such as thicken-
ing, inflammation, hyperplasia or accumulation of hya-
luronan at the lining layer may influence the passage of
hyaluronan into the lymphatic vessels and thus cause a
change of half-life of hyaluronan. But we found only
mild inflammatory signs and hyperplasia of the synov-
Tab. 6 Hyaluronan concentration and content of synovial fluids of normal and injured rabbit knee
joints. Values are given as mean ± SEM.
Hyaluronan concentration
[g/1]
Hyaluronan content
[mg/synovial fluid]
Non-operated group
2.04 ± 0.19
n = 6
0.91 ± 0.09
n = 6
Sham-operated group
1.99 ± 0.31
n = 3
1.65 ± 0.73
n = 3
Osteoarthritis group
"4 weeks after
operation"
1.61 ± 0.07
n = 4
1.53 ± 0.36
n = 4
Osteoarthritis group
"12 weeks after
operation"
2.27 ± 0.13
n = 3
2.01 ± 0.95
n = 3
362 Lindenhayn et al.: Clearance of hyaluronan from joints
ium, so that the reason for the half-life elevation in the
phase of developing osteoarthritis remains unclear.
The enhanced values of half-life of hyaluronan in the
phase of the developing osteoarthritis cannot be ex-
plained by the surgery because 2 out of 3 animals in the
sham-operated group showed normal half-lives. How-
ever, as a response to the sham operation (4 weeks after
operation), the volume of the synovial fluid in the sham-
operated knee joints was higher than in the knee joints
of the non-operated control animals (see tab. 3).
Heilmann et al. obtained similar results using amino-
pyridine- and fluoresceine-labelled hyaluronan (unpub-
lished results). Fluorescence-labelled hyaluronan had a
considerably lower intra-synovial half-life than [3H]hya-
luronan, which can be partially explained by the lower
Mr in comparison to the high molecular mass [3H]hya-
luronan. Using fluorescence-labelled hyaluronan, Heil-
mann et al. also found elevated half-lives in the rabbit
osteoarthritis model of Colombo et al. (unpublished re-
sults). However, the half-lives can only be determined
by following the content of fluorescence-labelled hyalur-
onan in the joint cavity (method I) because the fluores-
cent marker is quickly destroyed outside of the joint and
therfore is not detectable in the blood.
In interpreting clearance studies, both half-life as well
as intra-articular fluid volume, in which the injected
[3H]hyaluronan was distributed, must be taken into con-
sideration (23, 24), because the clearance rate of hyalur-
onan (volume of joint fluid cleared in unit time) depends
not only on the rate constant kHA (or ti/2) but also on
volume (clearance rate = k X distribution volume). If
the volume of synovial fluid is enhanced, then the mech-
anism removing hyaluronan from the joint must have
been enhanced. Whereas kHA of normal and osteoar-
thritic rabbit knee joints did not differ significantly at
the stage of developed osteoarthritis (tab. 4), the clear-
ance rates of the osteoarthritis group were considerably
higher in comparison to the non-operated control group
(tab. 3) due to the significantly higher synovial fluid
volumes of the osteoarthritis group (tab. 4).
The clearance of low molecular mass components such
as iodide (t/2: 0.6 to 1.3 hours) is interpreted as a mea-
sure of synovial plasma flow, whereas the clearance of
high molecular mass compounds such as albumin (t/2: 8
to 17 hours), hyaluronan (t/2: 11 to 31 hours) or proteo-
glycan (t./2: 12 to 17 hours) is considered as representing
the rate of lymphatic drainage from the joint (6, 25).
Brown et al. already suggested a common pathway for
the elimination of hyaluronan and proteoglycan mono-
mers from the joint cavity because of the striking sim-
ilarity between their half-lives (6).
Clearance and half-life of different high molecular mass
compounds were determined by several authors under
conditions of low and high grade synovitis. Myers et al.
provoked a mild synovitis by injection of 0.05 g
calcium pyrophosphate crystals into canine kneeijoints
(26) and found an increased albumin clearance but no
changed half-life of albumin, whereas in acute synovitis
induced by injection of 0.5 g or 500 g of calcium
pyrophosphate a marked decrease of half-life was ob-
served. Since Myers et al. presented only clearance val-
ues of their experiments, we calculated the correspond-
ing half-lives from data given in their publication. Page-
Thomas et al. determined the half-life of 131I-labelled
proteoglycan subunit in rabbit knee joints with and with-
out experimental arthritis (27). They found a half-life of
12.94 ± 0.63 hours for normal joints and a not signifi-
cantly altered half-life in the presence of an active syno-
vitis (14.49 ± 2.58 hours). Fräser et al. reported a gross
reduction in the half-life of hyaluronan in synovial fluid
in acute monoarticular arthritis induced by intra-articular
injection of type II collagen into sheep hock joints (22).
The half-life fell from 20.8 ± 1.8 hours to 11.5 ± 1.1
hours (mean ± SEM) with a corresponding increase in
mean fractional hyaluronan turnover from 3.5%/hour to
6.3%/hour. We suppose that the half-life of high molecu-
lar compounds in the joint seems not to be altered under
conditions of a low grade synovitis, as seen in the rabbit
model of osteoarthritis or in the model of Myers et al.
(26), whereas under inflammatory conditions the half-
life is grossly reduced. At present we do not know the
reason for the elevated half-life of hyaluronan in the
osteoarthritis model of Colombo et al. when osteoarthri-
tis is developing.
Our investigation was done with regard to an early diag-
nosis of osteoarthritis, which is urgently needed. Such
investigations can be carried out on human beings only
on a very limited scale, thus animal models have to be
used. In contrast to human osteoarthritis, animal models
of osteoarthritis allow the development of the disease
in a relatively short time, enable pathophysiologic and
pathobiochemical investigations of joint components
and allow it to follow the process of the disease accu-
rately. We chose the rabbit model of osteoarthritis be-
cause meniscectomy and ligament damage result in pro-
gressive degenerative changes of the joint which are
similar to that in human osteoarthritis. It has to be
proven whether the estimation of half-life of hyaluronan
in the joint fluid will be of any value to the early diagno-
sis of human osteoarthritis.
It is difficult to discuss the hyaluronan concentrations of
the synovial fluids in our groups (tab. 6) because hyalur-
onan concentration depends on different factors:
(i) synthesis by the lining cells,
(ii) half-life of hyaluronan in the joint fluid and
(iii) hyaluronan accumulation in the joint.
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Hyaluronan presumably accumulates in the joints dur-
ing rest and is removed by physical exercise (7). In
the normal joint the main deposit seems to be in the
lining layer while in the swollen inflamed synovium
the hyaluronan is distributed throughout the perivascu-
lar spaces (7). Therefore, we are not able to answer
the question of why the hyaluronan concentration is
decreased in osteoarthritis although hyaluronan synthe-
sis is enhanced by osteoarthritic synovium and the
half-life of hyaluronan is increased and unchanged,
respectively. In the rabbit model of Colombo et al. the
hyaluronan concentrations seem to be lowered at the
stage of developing osteoarthritis but not at the stage
of developed osteoarthritis.
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